Skip to main content
TipRanks
Go Ultimate75% OFF

BioMark Diagnostics (BUX) Income Statement

3 Followers

BioMark Diagnostics Income Statement

Last quarter (Q4 2026), BioMark Diagnostics's total revenue was C$7.01K, a decrease of 82.03% from the same quarter last year. In Q4, BioMark Diagnostics's net income was C$-199.47K. See BioMark Diagnostics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 26Jun 25Jun 24Jun 22Jun 21
C$ 59.79KC$ 154.22KC$ 163.22KC$ 153.49KC$ 0.00
C$ -322.49KC$ 154.22KC$ 163.22KC$ -232.70KC$ -13.69K
C$ 1.55MC$ 2.06MC$ 1.48MC$ 1.89MC$ 1.08M
Depreciation and AmortizationC$ 382.28KC$ 401.27KC$ 393.17KC$ 386.20KC$ 13.69K
C$ -1.49MC$ -1.46MC$ -919.05KC$ -1.35MC$ -1.08M
C$ -1.87MC$ -1.91MC$ -1.32MC$ -1.84MC$ -1.09M
C$ 268.36KC$ -19.14KC$ -110.67KC$ -110.15KC$ -596.00
C$ -1.60MC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09M
C$ -1.48MC$ -1.93MC$ -1.43MC$ -1.84MC$ -1.09M
Per Share Metrics
Basic EPSC$ -0.01C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Diluted EPSC$ -0.01C$ -0.02C$ -0.02C$ -0.02C$ -0.01
Weighted Average Shares Outstanding105.09M85.24M85.24M82.78M73.30M
Weighted Average Shares Outstanding (Diluted)105.09M85.24M85.24M82.78M73.30M

Currency in CAD

BioMark Diagnostics Earnings and Revenue History

-2.4M-1.2M01.2M-3000 %-2000 %-1000 %0 %EarningsProfit Margin20172018201920212022202420252026RevenueEarningsProfit Margin